Weight loss prior to diagnosis of first-episode psychosis predicts subsequent weight gain: a retrospective cohort study of the UK Clinical Practice Research Datalink (CPRD) primary care database - Report - MDSpire

Weight loss prior to diagnosis of first-episode psychosis predicts subsequent weight gain: a retrospective cohort study of the UK Clinical Practice Research Datalink (CPRD) primary care database

  • By

  • Brian O’Mahony

  • Richard I G Holt

  • Emanuele F Osimo

  • Karla V.B Hitchins

  • Brian O’Donoghue

  • Benjamin I Perry

  • July 16, 2026

Share

Pre-Diagnosis Weight Loss in First-Episode Psychosis Linked to Future Weight Gain

Overview

This study investigates the prevalence of weight loss prior to the diagnosis of first-episode psychosis (FEP) and its impact on subsequent weight gain. Findings indicate that individuals with pre-FEP weight loss gain weight post-diagnosis at more than double the rate of those without prior weight loss.

Background

Weight gain is a common and rapid occurrence in individuals experiencing first-episode psychosis. Understanding pre-diagnosis weight changes is crucial, as they may influence post-treatment weight trajectories. This study aims to investigate pre-FEP weight loss and its association with future weight gain.

Data Highlights

MeasureWeight Loss Pre-FEPWeight Gain Post-FEP
Percentage Weight Change53% experienced weight loss8.93% per year (with loss) vs 4.07% per year (without loss)
Annual Weight GainAverage loss: 4.83 kgAverage gain: 6.49 kg

Key Findings

  • 53% of individuals experienced weight loss prior to FEP diagnosis.
  • Individuals with pre-FEP weight loss gained weight post-diagnosis at a rate of 8.93% body weight per year compared to 4.07% for those without prior loss.
  • Each 1% of pre-FEP weight loss predicted an additional 0.41% annual weight gain post-diagnosis.
  • Average weight gain in the first year post-diagnosis (6.49 kg) exceeded average weight loss prior to diagnosis (4.83 kg).
  • Findings were consistent across sensitivity analyses.

Clinical Implications

Clinicians should inquire about weight changes during the pretreatment phase in individuals with FEP, as this may predict weight gain following diagnosis.

Conclusion

Pre-diagnosis weight loss is prevalent in first-episode psychosis and is associated with subsequent weight gain.

Related Resources & Content

  1. Weight loss prior to diagnosis of first-episode psychosis predicts subsequent weight gain: A retrospective cohort study of the UK Clinical Practice Research Datalink (CPRD) primary care database.
  2. Recommendations | Psychosis and schizophrenia in adults: prevention and management | Guidance | NICE
  3. Obesity Surgery — Exploring the Intricate Link Between Bariatric Surgery and Depression: Findings from a National Nested-Control Study
  4. Obesity Surgery — Influence of Preoperative Mental Health Assessment on Long-term Weight Loss Outcomes Following Bariatric Surgery
  5. The Journal of Clinical Endocrinology & Metabolism — The Influence of Weight Patterns on the Risk of Ten Different Cardiometabolic Disorders
  6. Obesity Surgery — Self-Reported Pleasure-Seeking Behavior as a Predictor of Weight Loss Outcomes One Year Post-Roux-en-Y Gastric Bypass
  7. Recommendations | Psychosis and schizophrenia in adults: prevention and management | Guidance | NICE
  8. https://academic.oup.com/eurheartj/article/46/41/4156/8234498
  9. Checking your browser - reCAPTCHA
  10. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  11. Predicting antipsychotic-induced weight gain in first episode psychosis – A field-wide systematic review and meta-analysis of non-genetic prognostic factors - PMC
  12. Weight loss prior to diagnosis of first-episode psychosis predicts subsequent weight gain: A retrospective cohort study of the UK Clinical Practice Research Datalink (CPRD) primary care database.
  13. Patterns of symptoms before a diagnosis of first episode psychosis: a latent class analysis of UK primary care electronic health records - PMC
  14. Pharmacological interventions to manage cardiometabolic outcomes in adults with severe mental illness: umbrella review | The British Journal of Psychiatry | Cambridge Core
  15. Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: A systematic review and meta-analysis - PubMed
  16. The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis
  17. Empagliflozin as an Alternative to Metformin for Antipsychotic-Related Weight Gain: Double-Blind Randomized Controlled Trial - PubMed

Original Source(s)

Related Content